Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GUSELKUMAB
- Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis
- A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Immune Spatial Features of Guselkumab Cutaneous Response
- A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection
- Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)
- Biologics and Blistering
- A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
- A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
- Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
- Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
- A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
- Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis
- A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis
- COVID-19 VaccinE Response in Rheumatology Patients
- A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
- Multi-Center PAMPA Study
- Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
- A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
- A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis
- A Study of Guselkumab in Participants With Active Psoriatic Arthritis
- Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease
- A Study of Guselkumab in Adult Participants With Celiac Disease
- A Study of Guselkumab in Participants With Systemic Sclerosis
- Guselkumab Immunogenetics
- A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis
- A Study of Intravenous Formulation of Guselkumab Using Prefilled Syringes and Final Vialed Product in Healthy Participants
- A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
- An Explorative Psoriasis Biomarker Study
- A Study of Guselkumab in Participants With Active Lupus Nephritis
- Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis
- A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants
- Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.
- A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
- Study of Guselkumab and Ustekinumab Following a Single Intravenous or Subcutaneous Administration in Healthy Chinese Participants
- A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis
- A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis
- A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy
- A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
- A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
- A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants
- A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
- A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)
- A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis
- A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis
- A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
- Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
- An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis
- A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Participants
- Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis
- An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
- An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis
- Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)
- A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
- A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
- A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
- An Exploratory Genetic Study in Participants With Psoriasis
- A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants
Clinical trials list
click for details